PL326490A1 - Treatment of traumatic brain injuries - Google Patents

Treatment of traumatic brain injuries

Info

Publication number: PL326490A1
Authority: PL; Poland
Prior art keywords: treatment; traumatic brain; brain injuries; injuries; traumatic
Prior art date: 1995-11-06

Application number

PL96326490A

Inventor

Brian R Pike

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-06

Filing date

1996-11-05

Publication date

1998-09-28

1996-11-05 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1998-09-28 Publication of PL326490A1 publication Critical patent/PL326490A1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL96326490A 1995-11-06 1996-11-05 Treatment of traumatic brain injuries PL326490A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK123295		1995-11-06
PCT/DK1996/000458 WO1997017074A1 (en)	1995-11-06	1996-11-05	Treatment of traumatic brain injury

Publications (1)

Publication Number	Publication Date
PL326490A1 true PL326490A1 (en)	1998-09-28

Family

ID=8102484

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL96326490A PL326490A1 (en)	1995-11-06	1996-11-05	Treatment of traumatic brain injuries

Country Status (18)

Country	Link
EP (1)	EP0866706A1 (en)
JP (1)	JPH11514654A (en)
KR (1)	KR19990067353A (en)
AU (1)	AU706594B2 (en)
BG (1)	BG63150B1 (en)
BR (1)	BR9611396A (en)
CA (1)	CA2234824A1 (en)
CZ (1)	CZ287441B6 (en)
EA (1)	EA000531B1 (en)
HU (1)	HUP9901051A2 (en)
IS (1)	IS4726A (en)
NO (1)	NO982036L (en)
NZ (1)	NZ321546A (en)
PL (1)	PL326490A1 (en)
SK (1)	SK58198A3 (en)
TR (1)	TR199800801T2 (en)
WO (1)	WO1997017074A1 (en)
ZA (1)	ZA969320B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR013096A1 (en) *	1997-07-01	2000-12-13	Lundbeck & Co As H	SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1928437A2 (en)	2005-08-26	2008-06-11	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
CA2625153A1 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
EP2382975A3 (en)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
US20100216805A1 (en)	2009-02-25	2010-08-26	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8714789D0 (en) *	1987-06-24	1987-07-29	Lundbeck & Co As H	Heterocyclic compounds
US5328925A (en) *	1989-02-22	1994-07-12	Novo Nordisk A/S	Piperidine compounds and their use
IE922270A1 (en) *	1991-07-26	1993-01-27	Akzo Nv	Pyrazole derivatives
US5330994A (en) *	1992-03-24	1994-07-19	Warner-Lambert Company	Tetrahydropyridine isoxazoline derivatives

1996
- 1996-11-05 SK SK581-98A patent/SK58198A3/en unknown
- 1996-11-05 HU HU9901051A patent/HUP9901051A2/en unknown
- 1996-11-05 EA EA199800434A patent/EA000531B1/en not_active IP Right Cessation
- 1996-11-05 KR KR1019980703360A patent/KR19990067353A/en not_active Application Discontinuation
- 1996-11-05 JP JP9517762A patent/JPH11514654A/en active Pending
- 1996-11-05 BR BR9611396A patent/BR9611396A/en not_active Application Discontinuation
- 1996-11-05 NZ NZ321546A patent/NZ321546A/en unknown
- 1996-11-05 AU AU74900/96A patent/AU706594B2/en not_active Ceased
- 1996-11-05 TR TR1998/00801T patent/TR199800801T2/en unknown
- 1996-11-05 WO PCT/DK1996/000458 patent/WO1997017074A1/en not_active Application Discontinuation
- 1996-11-05 CZ CZ19981389A patent/CZ287441B6/en not_active IP Right Cessation
- 1996-11-05 EP EP96937193A patent/EP0866706A1/en not_active Ceased
- 1996-11-05 PL PL96326490A patent/PL326490A1/en unknown
- 1996-11-05 CA CA002234824A patent/CA2234824A1/en not_active Abandoned
- 1996-11-06 ZA ZA969320A patent/ZA969320B/en unknown
1998
- 1998-04-27 IS IS4726A patent/IS4726A/en unknown
- 1998-05-05 NO NO982036A patent/NO982036L/en not_active Application Discontinuation
- 1998-05-22 BG BG102480A patent/BG63150B1/en unknown

Also Published As

Publication number	Publication date
BG63150B1 (en)	2001-05-31
MX9803432A (en)	1998-09-30
ZA969320B (en)	1997-05-30
CZ138998A3 (en)	1998-10-14
BG102480A (en)	1999-01-29
CA2234824A1 (en)	1997-05-15
AU706594B2 (en)	1999-06-17
NO982036L (en)	1998-06-25
JPH11514654A (en)	1999-12-14
WO1997017074A1 (en)	1997-05-15
BR9611396A (en)	1999-07-13
IS4726A (en)	1998-04-27
SK58198A3 (en)	1998-10-07
CZ287441B6 (en)	2000-11-15
EA000531B1 (en)	1999-10-28
EP0866706A1 (en)	1998-09-30
NO982036D0 (en)	1998-05-05
TR199800801T2 (en)	1998-08-21
EA199800434A1 (en)	1998-10-29
NZ321546A (en)	2000-12-22
AU7490096A (en)	1997-05-29
KR19990067353A (en)	1999-08-16
HUP9901051A2 (en)	2000-03-28

Publication	Publication Date	Title
AU1436595A (en)	1995-07-17	Method of treatment of traumatic brain injury
ZA96740B (en)	1997-07-31	Skin treatment composition
HU9603369D0 (en)	1997-01-28	Treatment of vegetables
ZA969520B (en)	1997-05-14	Use of epinastine for the treatment of pain
GB9500247D0 (en)	1995-03-01	Treatment of poultry
EP0795035A4 (en)	1998-03-11	Treatment of hides
PL326490A1 (en)	1998-09-28	Treatment of traumatic brain injuries
IL131347A0 (en)	2001-03-19	Treatment of skin disorders
GB2303303B (en)	1999-09-15	Medical treatment
GB9419048D0 (en)	1994-11-09	Treatment of muscular disorders
GB9521725D0 (en)	1996-01-03	Medical treatment
GB9510162D0 (en)	1995-07-12	Compositions for the treatment of skin conditions
EP0828507A4 (en)	2000-10-18	Method for treatment of pain
EP0782631A4 (en)	1999-03-24	Treatment of plasmodium
GB9507825D0 (en)	1995-05-31	Method of treatment
GB9526264D0 (en)	1996-02-21	Medical treatment
GB9400600D0 (en)	1994-03-09	Treatment of motion seckness
GB9216360D0 (en)	1992-09-16	Treatment of blood
AU4128896A (en)	1996-06-17	Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury
GB9520495D0 (en)	1995-12-13	Treatment of medical conditions
GB9520496D0 (en)	1995-12-13	Treatment of medical conditions
GB9520494D0 (en)	1995-12-13	Treatment of medical conditions
GB9502742D0 (en)	1995-03-29	Treatment of hrt-associated breast pain
GB9503200D0 (en)	1995-04-05	Methods of treatment
GB9518723D0 (en)	1995-11-15	Treatment of coccidiosis